Browse Articles
Discover research articles across all indexed journals
Informing HIV vaccine design
Direct Writing High‐Resolution Quantum Dot Micro‐Patterns: Toward High‐Performance Electroluminescence Behavior
ABSTRACT The fabrication of quantum dots (QDs) micro‐patterns, especially those with both µm‐scale high‐resolution and mm‐/cm‐ scale large area uniformity, remains a bottleneck limiting the application of quantum dot light‐emitting diodes (QLEDs). Current strategies have suffered from either low resolution or complicated micro‐template assisted fabrications deteriorating the device performance. Here, we developed a new conceptual high‐resolution QDs micro‐pattern with a linewidth of merely 2 µm in an area of ∼10 cm 2 by a template‐free direct writing strategy, featured as the distinguishable QDs micro‐line array by the periodical nanoscale thickness difference. The enhanced capillary flow accelerates QDs deposition at each tri‐phase contact line in a positive feedback manner until the liquid film breaking, which proceeds uniformly across the whole printing area in a good periodicity. Thus, a periodic conformal complementary QDs/PMMA heterostructure bilayer film, composed of alternate thick‐QDs/thin‐PMMA and thin‐QDs/thick‐PMMA unit, was constructed as the light‐emitting layer, which facilitates the autonomous charge distribution at both inter‐ and intra‐ interface. The as‐developed high‐resolution micro‐patterned QLED shows an external quantum efficiency as high as 21.4% even at a linewidth of 2 µm. The result offers a low‐cost facile strategy for making large‐area high‐resolution micro‐patterned QLED devices.
Alternative Extracellular Disulfide Bond Formation by N-terminal Cysteines Supports Functional Expression of Odorant Receptors
Machine learning prediction of clinical tumor lysis syndrome in critically ill patients with hematologic malignancies using laboratory trajectory features: A MIMIC-IV retrospective cohort study.
263 Background: Tumor lysis syndrome (TLS) remains a life-threatening oncologic emergency in patients with hematologic malignancies admitted to the intensive care unit (ICU). Current risk stratification relies on static baseline factors such as malignancy type, white blood cell count, and lactate dehydrogenase (LDH) at presentation. Whether dynamic laboratory trajectories during the early ICU course can improve prediction of clinical TLS (CTLS) beyond baseline assessment alone has not been established. Methods: We conducted a retrospective cohort study using the MIMIC-IV database (v3.1). Adults (≥18 years) with high-risk hematologic malignancies, ICU admission, and complete TLS-defining laboratories (uric acid, potassium, phosphorus, calcium, creatinine) within 72 hours were included. Patients with pre-existing dialysis, prevalent TLS, or ICU stay <24 hours were excluded. CTLS was defined per Cairo-Bishop criteria. Trajectory features (slope, delta, peak, nadir, area under the curve) were extracted from serial measurements of seven analytes over 0–48 hours. A composite Metabolic Burden Score was derived from z-scores of peak uric acid, potassium, phosphorus, and nadir calcium. Three models (XGBoost, Random Forest, Logistic Regression) were trained on combined baseline and trajectory features and compared against a static-only baseline model. Model interpretability was assessed using SHAP analysis. Results: The final cohort comprised 415 patients (478 ICU stays) across eight malignancy subtypes. CTLS occurred in 129 patients (27.6%). CTLS was strongly associated with mortality (51.1% severe CTLS vs. 31.7% no TLS) and prolonged ICU stay (7.1 vs. 4.2 days). Patients with laboratory TLS alone had 0% mortality. Model performance and feature importance are shown in the Table. The trajectory-enhanced model improved AUC by 0.06 over static baseline alone (0.905 vs. 0.845). Three of the top five predictive features were dynamic trajectory variables, with Metabolic Burden Score ranking first (Table 1). Conclusions: In critically ill patients with hematologic malignancies, laboratory trajectory features derived from the first 48 hours of ICU admission substantially improve prediction of CTLS compared to static baseline risk factors. Dynamic monitoring of electrolyte and metabolite velocity may enable earlier identification of patients progressing toward clinical TLS. Model performance and top predictive features. AUC-ROC AUPRC Random Forest 0.940 0.897 XGBoost 0.905 0.874 Logistic Regression 0.902 0.858 Static Baseline Only (XGBoost) 0.845 — Top Feature (SHAP Rank) Type Mean |SHAP| 1. Metabolic Burden Score Dynamic 1.249 2. Creatinine slope Dynamic 0.779 3. Potassium delta max Dynamic 0.756 4. LDH slope Dynamic 0.669 5. Baseline uric acid Static 0.621
An integrative multi-omics machine learning framework for precision metastasis prediction and clinical staging in non-small cell lung cancer.
11 Background: Traditional TNM staging inadequately captures the biological aggressiveness of NSCLC. While cell cycle dysregulation is a cancer hallmark, its role in driving invasiveness remains under-characterized. We developed a Lasso-Logistic machine learning (ML) framework to integrate cell cycle transcriptomics for enhanced metastasis and staging prediction. Methods: We integrated multi-omics data from TCGA, GEO (n=3), and CPTAC, along with five scRNA-seq datasets. A 14-gene signature was identified through Lasso-Logistic regression to calculate a CCRS. The biological interpretability of the findings was ensured by employing scRNA-seq pseudotime trajectory inference. The model was validated both in vitro using four cell lines and ex vivo through RT-qPCR on cDNA microarrays with 15 paired tissues, as well as in an independent clinical cohort. Results: The ML framework identified a 14-gene signature (notably CCNB1, CDK1, CCNA2) with superior discriminative power. In the discovery meta-cohort, the model achieved an AUC of 0.879 for metastasis prediction, maintaining a C-index of 0.740 in the TCGA. scRNA-seq analysis confirmed that the CCRS genes were significantly upregulated along the EMT axis ( P < 0.001), identifying a specific "invasive-proliferative" cellular state. Ex vivo validation via RT-qPCR revealed significant transcriptional heterogeneity, with key drivers CCNA2 and CCNB1 exhibiting >10-fold upregulation in tumor versus adjacent normal tissues. In the independent clinical cohort, the model demonstrated a 75% accuracy in distinguishing pathological stages, outperforming individual gene markers. Conclusions: This study presents a rigorously validated machine learning framework that translates complex cell cycle transcriptomics into a clinically applicable tool. By bridging the gap between computational ‘big data' and bedside diagnostics, this framework provides a scalable solution for identifying high-risk NSCLC patients, thereby potentially facilitating the intensification of personalized treatment. Performance metrics of the multi-omics machine learning framework. Validation Level Source/Cohort (n) Biological/Clinical Target Performance Metric Statistical Result In silico (Training) GEO Meta-cohort Metastasis Prediction AUC 0.879 In silico (Test) TCGA-LUAD/LUSC Metastasis Prediction C-Index 0.740 Proteomics CPTAC (Proteome) Clinical Stage Correlation Spearman’s r Positive ( P < 0.05) Single-cell scRNA-seq (n=5) EMT Pseudotime Trajectory Wald Test P < 0.001 Experimental NSCLC Cell Lines Proliferation & Invasion mRNA Fold-change Significant (vs Normal) Clinical Ex vivo cDNA Microarray (n=12) Real-world Staging Accuracy 75.0% Key Driver 1 Clinical Tissue (n=15) CCNA2 Expression Tumor vs Normal > 10-fold ( P < 0.01) Key Driver 2 Clinical Tissue (n=15) CCNB1 Expression Tumor vs Normal > 10-fold ( P < 0.01)
A Water-Soluble Diarylethene Base for Light-Controlled pH Modulation in Biological Systems
Efficacy of historical context and exogenous features on deep learning for cooling load forecasting in chilled water plants
Inhibiting lactate transport reduces lung fibrosis
p53 regulates mitochondrial function and alpha-synuclein aggregation in Parkinson's disease
Circulating tumor suppressor microRNAs as minimally invasive biomarkers for early detection of colorectal cancer.
103 Background: Early diagnosis of colorectal cancer (CRC) remains a major clinical challenge contributing significantly to cancer-related mortality worldwide. Circulating microRNAs (miRNAs) are short non-coding RNAs that showed stability in plasma. The current was conducted to evaluate the diagnostic significance of plasma-derived tumor suppressor miRNAs that may be used as minimally invasive biomarkers for early detection of CRC. Methods: The present study recruited 75 participants, including CRC patients (n = 50) and healthy controls (n = 25), from a tertiary care hospital in Lahore, Pakistan, after institutional ethical approval. With written informed consent from each participant, peripheral blood was collected in EDTA tubes, and plasma was isolated for total RNA extraction. Complementary DNA was synthesized, and expression of selected tumor suppressor miRNAs was quantified using real-time quantitative PCR (qRT-PCR) in accordance with MIQE-compliant procedures. Relative expression was calculated using the 2⁻ ΔΔCt method. Diagnostic accuracy was assessed using receiver operating characteristic (ROC) curve analysis. Associations with clinicopathological parameters were analyzed using Spearman correlation. Results: Circulating tumor suppressor miRNAs were significantly downregulated in CRC patients compared with healthy controls ( p < 0.001). ROC curve analysis demonstrated high diagnostic performance, yielding 97.5% sensitivity and 94% specificity. Spearman correlation analysis showed no significant association between miRNA expression and clinicopathological parameters, indicating expression consistency across CRC clinical characteristics. Conclusions: Circulating tumor suppressor miRNAs demonstrate high diagnostic performance and may serve as reliable minimally invasive biomarkers for early detection of colorectal cancer. Validation studies in larger, multicenter cohorts are required to support clinical translation.
Association of a high-speed, knowledge-based AI tool at the primary care level with zero-miss triage and detection of incidental pulmonary nodules.
270 Background: In mainland China, the high accessibility and remarkably low out-of-pocket cost of chest computed tomography (CT) scans (approximately $26 USD) have led to widespread screening and a subsequent surge in the detection of incidental pulmonary nodules (IPNs). However, a severe shortage of thoracic specialists and inadequate specialized training among primary care physicians have created a critical bottleneck. This systemic gap disproportionately impacts older adults, who often lack the capacity to independently navigate complex healthcare networks to seek specialized care, making them highly vulnerable to critical delays in the treatment of high-risk nodules. To address this, we developed a novel artificial intelligence (AI) tool designed to assist primary care providers in identifying high-risk patients for prompt referral, bypassing the need for heavy DICOM image data transfers. Methods: We developed an ultra-fast, text-based AI diagnostic tool utilizing a knowledge-base architecture rather than traditional data-heavy deep learning models. This knowledge-driven approach significantly reduced the dependency on massive datasets, allowing the model to be robustly constructed and trained using a highly curated cohort of only 500 expertly annotated CT reports. The algorithm extracts and interprets radiographic terminology directly from the text to stratify IPN risk. To confirm the tool's clinical reliability and generalizability, it was subsequently tested and validated on a large, independent real-world cohort of over 3,000 cases. Results: By leveraging a knowledge-base design and focusing exclusively on report text, the AI tool demonstrated exceptional computational efficiency, achieving a processing speed of 10 reports per second. In the large-scale validation cohort (n > 3,000), the tool achieved an impressive overall accuracy of 96.3% in risk stratification. Most crucially, the model yielded a false-negative rate of 0%. This zero-miss rate ensures that absolutely no high-risk patients are overlooked or misclassified as low-risk, guaranteeing maximum patient safety in grassroots medical settings. Conclusions: By employing a knowledge-base architecture, this ultra-fast, report-based AI tool achieves high accuracy and a zero-miss rate with minimal training data. By completely eliminating false negatives, it empowers primary care physicians to make reliable referral decisions. This tool is exceptionally meaningful for older adults with cancer; by providing expert-level triage directly at the primary care level, it overcomes their diminished capacity to independently seek out specialists, effectively preventing life-threatening delays in high-risk cases while protecting low-risk older patients from the hazards of overtreatment and unnecessary invasive procedures.
Targeting rapidly cycling receptors CD2 and CD7 increases nanoparticle delivery to primary CD4+ T cells
Abstract T cells are critically important to many diseases but are traditionally difficult to transfect. We hypothesise that the delivery of therapeutic cargo to T cells can be improved by targeting nanoparticles to surface receptors that undergo rapid receptor-mediated endocytosis. Using an internalisation assay that labelled intracellular and surface proteins with different fluorophores, we find that CD2 and CD7 exhibit significantly higher internalisation than other T cell receptors, such as CD3 or CD4. Targeting CD2 and CD7 improves nanoparticle internalisation by non-stimulated, primary CD4 + T cells and enhances the specificity of association to CD4 + T cells. Similarly, functionalising mRNA-lipid nanoparticles with antibodies targeting CD2 or CD7 enhances mRNA delivery to CD4 + T cells in vitro. Importantly, targeting CD2 or CD7 enables efficient lipid nanoparticle-mediated delivery of mRNA to T cells in blood and lymphoid tissue in vivo, demonstrating that targeting T cell receptor endocytosis can enhance nanoparticle-mediated drug delivery to T cells.
Mass spectrometry-based proteomics to study gastric carcinogenesis: pathophysiological molecular characterization
Inhibiting Nipah virus
MOF‐Induced Pore Confinement: A Strategy for Thermomechanically Robust and High‐Strength Liquid Crystal Elastomers
ABSTRACT Liquid crystal elastomers (LCEs) are premier candidates for soft robotics due to their large, reversible actuation. However, their utility is often restricted by a fundamental trade‐off: as temperature increases, orientational order diminishes, causing a sharp loss in load‐bearing capacity and actuation stress above the isotropic transition. Here, we report a sequential integration strategy that overcomes this thermal limitation by embedding ultrathin Cu‐TCPP metal‐organic framework (MOF) nanosheets within the LCE network. This approach establishes a pore‐confinement‐enabled architecture that restricts segmental relaxation and preserves molecular alignment even under harsh thermal conditions. The resulting LCE‐MOF composites exhibit exceptional mechanical robustness, achieving a tensile strength of 79 MPa at 25°C and maintaining 4.2 MPa at 200°C. Notably, the materials deliver a high actuation stress of 3.9 MPa at 200°C, significantly outperforming composites fabricated via conventional direct mixing. This confinement strategy effectively decouples mechanical integrity from thermal transitions, as demonstrated by a high‐performance passive thermal valve capable of reliable switching in extreme environments. Our work provides a versatile methodology for designing resilient, high‐output soft actuators for aerospace, industrial, and high‐temperature hazardous applications where thermal stability and reliable actuation are critically demanded.
Coordinated Skin‐Electrode Deformation for Switchable Adhesion and Injury‐Free Detachment of Epidermal Electrodes
ABSTRACT Human‐machine interfaces require thin and conformal epidermal electrodes to detect physiological signals from the human body. A key challenge of such epidermal electrodes is to combine two contradictory but highly desired properties: stable electrode‐skin adhesion that enables high‐fidelity signal acquisition, and poor adhesion for easy and injury‐free removal. Here, we report a soft conducting electrode that well combines the two contradictory properties by tailoring a T‐shaped finger and a U‐shaped finger and by tuning the stickiness to a mild level. When peeling from the U‐finger to the T‐finger, the two fingers “pinch” the skin with a large co‐deformation between the skin and the electrode for enhanced adhesion. When peeling back, the U‐finger is disabled, and the electrode behaves like a non‐patterned layer that exhibits poor adhesion for easy detachment. The kirigami‐enabled co‐deformation of bilayer soft system with a thin surface and thick substrate for switchable adhesion and low interfacial damage might be extended to other human‐machine interfaces and beyond.
Molecular and Structural Dissection of Psalmopoeus pulcher Venom Reveals Cysteine-Rich Peptides that Target Acid-Sensing Ion Channel 1a
Kaposi's Sarcoma in patients exposed to calcineurin inhibitors or systemic corticosteroids: A two-decade real-world safety assessment.
356 Background: Kaposi’s Sarcoma (KS) is a rare angioprolefrative tumor, occurring in approximately 2 per 1 million in the United States. Although the iatrogenic variant is primarily linked to immunosuppressive therapy, evidence on drug specific-induced KS risk remains limited. This study assesses the association between KS and exposure to immunosuppressive agents. Methods: We conducted a retrospective pharmacovigilance analysis using U.S. Food and Drug Administration's Adverse Event Reporting System (FAERS), retrieving reports involving calcineurin inhibitors and corticosteroids from 2004 Q1 to 2024 Q1, Disproportionality analyses were performed by Reporting Odds Ratios (RORs), Proportional Reporting Ratios (PRR), and Bayesian shrinkage metrics, including the Information Component and its lower 95% credibility bound (IC025). A signal was considered present when IC025 exceeded zero. Descriptive analyses were also performed. All data cleaning and statistical analyses were performed in R (version 2025.09.2+418). Results: A total of 668 reports of KS in patients exposed to cyclosporine, tacrolimus, prednisone, or methylprednisolone were identified. Prednisone demonstrated the strongest disproportionality signal (n=175, ROR 40.14 [34.42-46.80], PRR 39.91, IC025 5.01), followed by tacrolimus (n=241, ROR 31.12 [27.2-35.5], PRR 30.9, IC025 4.65), methylprednisolone (n= 97, ROR 27.62 [22.5-33.8], PRR 27.5, IC025 4.44) and cyclosporine(n=155, ROR 23.58 [20.0-27.7], PRR 23.5, IC025 4.25). KS occurred predominantly in males (68.1%), with a median age of 54 years, and was most frequently associated with renal transplant indications (10.8%). Mortality was highest with cyclosporine-associated cases (21.9%). Time-to-onset analysis revealed the shortest latency with methylprednisolone (median 51.5 days), while tacrolimus showed the longest latency (median 344.5 days). Conclusions: Although FAERS cannot distinguish iatrogenic KS from other variants, all four agents showed strong signals for KS. Cyclosporine associated cases had the highest mortality. and the marked differences in latency patterns between corticosteroids and calcineurin inhibitors suggest distinct drug class risk profiles.
A single-cell multi-omic atlas of extrahepatic cholangiocarcinoma progression with ST6GAL1-enriched preinvasive states.
176 Background: Extrahepatic cholangiocarcinoma (eCCA) is frequently diagnosed at advanced stages, limiting opportunities for early intervention. Chronic biliary inflammation is a recognized risk context, however, the cellular and epigenetic changes linking inflammatory injury to preinvasive lesions and invasive eCCA remain incompletely defined. We generated a stage-resolved single-cell multi-omic atlas to characterize this progression and prioritize candidates associated with preinvasive remodeling. Methods: Fresh human biliary tissues spanning the disease continuum (normal bile duct (n=2), inflammatory lesions (n=7), intraductal papillary neoplasm of the bile duct (IPNB; n=3), and invasive eCCA including perihilar (n=8) and distal (n=4) subtypes) were profiled using integrated single-cell RNA sequencing (scRNA-seq) and single-cell ATAC sequencing (scATAC-seq). Analyses included cross-sample integration, cell-type annotation, epithelial trajectory inference, copy-number inference, chromatin accessibility dynamics, and cross-modal candidate prioritization. Candidate genes were further evaluated using donor-level pseudo-bulk expression profiling across pathological stages. Results: We resolved an epithelial progression continuum characterized by increasing transcriptional reprogramming and genomic instability, with copy-number abnormalities detectable before overt invasion. IPNB exhibited substantial epithelial heterogeneity, consistent with branching preinvasive states. Cross-modal prioritization highlighted ST6GAL1 as a candidate associated with preinvasive remodeling. Donor-level pseudo-bulk profiling showed stage-dependent ST6GAL1 expression, with enrichment from inflammatory lesions/EBD to IPNB and sustained expression across invasive eCCA subtypes, consistent with preinvasive-enriched, stage-dynamic remodeling. Conclusions: This study provides a stage-resolved single-cell multi-omic map of eCCA progression from biliary inflammation to invasion and defines ST6GAL1-enriched preinvasive states as a translationally relevant feature for biomarker development and early interception studies.